A major study published in The Lancet Digital Health found that serious statin-related muscle damage is exceptionally rare. Researchers also developed a personalized risk prediction tool to help doctors identify patients most likely to experience severe muscle side effects, reinforcing that the cardiovascular benefits of statins far outweigh their small risk for most people.